LillyDirect Foundayo logo

LillyDirect Foundayo Review

Best for: patients with commercial insurance who want the cheapest legal brand-name GLP-1

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
8.5
★★★★4.3
BrandFoundayoAll 50 StatesLilly Savings CardManufacturer Direct
$149/mo
Price rises with dose
See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

LillyDirect Foundayo is one of the most affordable GLP-1 options on the market.

Score: 8.5/10Best for: patients with commercial insurance who want the cheapest legal brand-name GLP-1From: $149/mo
LillyDirect Foundayo logo
4.3 / 5
Our editorial rating
Visit LillyDirect Foundayo

from $25/mo · no insurance needed

LillyDirect Foundayo at a glance

Type
GLP-1 telehealth provider
Starting price
$25/mo (Requires commercial insurance; Medicare/Medicaid not eligible. 'Starting at $25 per month'.)
Pricing model
Scales with dose — higher doses cost more
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored LillyDirect Foundayo

Each dimension is scored algorithmically from LillyDirect Foundayo’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

8.9/10

At $149/mo, LillyDirect Foundayo runs about 12% below the $170 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.

Effectiveness25%

8.6/10

LillyDirect Foundayo offers orforglipron, an oral GLP-1 with promising late-stage trial data. FDA-approved brand options are available alongside compounded versions.

User Experience15%

7.9/10

Online intake and platform experience; 5 platform features disclosed.

Trust & Safety15%

8.8/10

Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).

Accessibility10%

9.3/10

LillyDirect Foundayo treats patients in all 50 states.

Support10%

6.9/10

LillyDirect Foundayo provides standard clinician follow-up; no extended coaching or community program is disclosed.

How we verified this LillyDirect Foundayo review

Last checked 2026-06-06
  • Confirmed current pricing across 5 dose/plan tiers
  • Confirmed availability in all 50 states
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.

GLP-1 medications LillyDirect Foundayo offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Foundayo (with commercial insurance + savings card)Brand-name
$25/mo
orforglipron

Requires commercial insurance; Medicare/Medicaid not eligible. 'Starting at $25 per month'.

Foundayo 0.8 mg (self-pay)Brand-name
$149/mo
orforglipron

Regular self-pay price, 1-month (30-day) supply.

Foundayo 2.5 mg (self-pay)Brand-name
$199/mo
orforglipron

Regular self-pay price, 1-month supply.

Foundayo 5.5 mg & 9 mg (self-pay)Brand-name
$299/mo
orforglipron

Regular self-pay price, 1-month supply.

Foundayo 14.5 mg & 17.2 mg (self-pay)Brand-name
$349/mo
orforglipron

Regular self-pay price $349; available for $299 via an automatic purchase offer ONLY if you complete your refill within 45 days of the delivery/receipt date of your previous Foundayo fill (14.5/17.2 mg only).

Ready to get started?

Plans and promotions change often — check LillyDirect Foundayo's current pricing and active discounts before you decide.

See LillyDirect Foundayo pricing →

What we like

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Watch-outs

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

LillyDirect Foundayo: the drugmaker selling its own pill to you

Most providers on this site are telehealth companies or pharmacies that source a GLP-1 and resell it to you. LillyDirect Foundayo is something different: it is Eli Lilly, the manufacturer itself, selling its brand-name weight-loss pill straight to patients with no middleman, no compounding, and no reseller markup. Foundayo is the consumer brand for orforglipron, the first oral (pill-form) GLP-1 cleared for weight loss. If you have a valid prescription and you want the genuine, FDA-cleared branded product at the lowest price anyone is legally allowed to charge, this is the channel that sets the floor. The honest catch is that LillyDirect is a fulfillment pipe, not a clinic — it will not see you, prescribe for you, or hold your hand.

How the pricing actually works (two completely different prices)

There are really two Foundayo prices, and which one applies to you depends entirely on your insurance. If you are covered by commercial (employer or marketplace) insurance, the Lilly Savings Card brings your cost down to roughly twenty-five dollars a month — the cheapest legal path to any brand-name GLP-1 in 2026. That number is not telehealth marketing; it is the manufacturer subsidizing its own list price to win the oral-GLP-1 market. The hard limit: Medicare and Medicaid patients are explicitly not eligible for that card, which knocks out a large share of the people who most want a cheaper option.

If you are paying cash, the price is not one flat figure — it climbs with your dose. The entry dose starts at $149 a month, and the regular self-pay price steps up from there as you titrate to higher strengths, topping out in the mid-three-hundreds for the strongest doses. For reference, the category median across providers we track is about $170, so the low doses undercut the field while the top doses sit near the middle. Lilly also runs an automatic refill offer that shaves the highest two doses down a notch — but only if you reorder within a tight 45-day window of your last delivery, so it rewards staying on schedule and penalizes gaps.

  • Commercially insured: about twenty-five dollars a month with the Lilly Savings Card
  • Cash-pay, low dose: starts at $149/month
  • Cash-pay, high dose: scales up into the mid-three-hundreds, with a conditional refill discount on the top strengths
  • Medicare / Medicaid: not eligible for the savings card — you pay cash rates

A daily pill, not an injection

The product itself is the real story. Orforglipron is a once-daily oral GLP-1 — no needles, no auto-injectors, no refrigeration, no compounding pharmacy in the chain. For people who have avoided GLP-1s purely because of the injection, that removes the single biggest barrier. It ships from LillyDirect's own pharmacy in all 50 states, so geography is not a problem the way it is with some compounders.

But the pill comes with a rule you have to respect: it must be taken on an empty stomach, with no more than a sip of water, and you wait about 30 minutes before eating, drinking, or taking other oral medications. Miss that window routinely and you blunt the drug. For a disciplined morning-routine person that is trivial; for someone with a chaotic schedule or other morning pills, it is a genuine friction point worth being honest about.

What it won't do: write your prescription

This is the part that trips people up. LillyDirect Foundayo is a pharmacy and pay channel — it does not include a medical visit, and it will not generate the prescription for you. You need a valid US prescription from a separate licensed prescriber (your own doctor, or an independent telehealth provider) before this channel can fill anything. So budget for that: a separate consult or visit fee somewhere else is part of the true cost of getting started here, even though the drug price looks low in isolation.

Be honest about the weight loss

Cheapest and easiest does not mean strongest. By the numbers in its own prescribing information, Foundayo's labeled-dose mean weight loss lands around 11% — real and clinically meaningful, but below injectable semaglutide (Wegovy, in the neighborhood of 15%) and well below tirzepatide (Zepbound, around 21%). If your goal is the maximum possible weight loss and you can tolerate a weekly shot, an injectable will likely take you further. Foundayo's pitch is convenience, brand-name legitimacy, and price — not peak efficacy.

Who should choose it, and who should skip it

  • Choose it if: you have commercial insurance and want a genuine brand-name GLP-1 for about twenty-five dollars a month, you strongly prefer a pill over injections, or you specifically distrust compounded products and want the manufacturer's exact product.
  • Skip it if: you are on Medicare or Medicaid (no savings card), you want an all-in-one service that prescribes and ships together, you can't reliably hold the empty-stomach window, or you are chasing the largest possible weight loss and would do better on an injectable.

Trust and oversight

On the safety axis this is about as clean as it gets. The product is brand-name, FDA-cleared, dispensed by the manufacturer's own pharmacy — there is no compounding, no third-party sourcing, and no FDA warning letter on file for this channel. What you are NOT buying is clinical care: there is no built-in medical team monitoring your dose or side effects, because that responsibility stays with whoever wrote your prescription. So the oversight is excellent on product quality and intentionally absent on patient management. See our scoring methodology for how we weigh that split.

Bottom line

LillyDirect Foundayo is the price floor and the legitimacy benchmark for oral GLP-1s in 2026. If you are commercially insured and already have a prescriber, almost nothing beats it on cost-per-real-brand-drug, and the daily-pill format is a genuine quality-of-life win. The trade-offs are equally clear: you bring your own prescription and your own clinical follow-up, the savings card excludes government insurance, the empty-stomach rule demands discipline, and the weight loss, while real, trails the strongest injectables. Buy it for what it is — a clean, cheap, manufacturer-direct supply of a brand-name pill — not for the full-service experience it doesn't pretend to offer.

Ready to start with LillyDirect Foundayo?

Starting at $149/month. See current pricing and start your free consultation.

LillyDirect Foundayo might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If the lowest possible monthly price is your top priority, consider Telos Rx (from $49/mo).
  • If you want built-in coaching and behavior-change support, consider Found.

Alternatives to LillyDirect Foundayo

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →
8.5/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.3

Editorial score · methodology

$179/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this LillyDirect Foundayo review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.

Ready to start with LillyDirect Foundayo?

Starting at $149/month. See current pricing and start your free consultation.